US 8927709
Hepatitis C virus inhibitors
granted A61PA61P1/16A61P31/14
Quick answer
US patent 8927709 (Hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P1/16, A61P31/14